Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL

Nature Genetics

Volumn 18, Issue 2, 1998, Pages 126-135

  He, Li Zhen ^a   Guidez, Fabien ^b   Tribioli, Caria ^a   Peruzzi, Daniela ^a   Ruthardt, Martin ^c,d   Zelent, Arthur ^b   Pandolfi, Pier Paolo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR; TRICHOSTATIN A;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME TRANSLOCATION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR GENE; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; TRETINOIN; TUMOR SUPPRESSOR PROTEINS; ZINC FINGERS;

EID: 0031941912     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0298-126     Document Type: Article

References (59)

1. Grignani, F. et al. Acute promyelocytic leukaemia: from genetics to treatment. Blood 83, 10-25 (1994).
2. Warrell, R.P., Jr., de The, H., Wang, Z.Y. & Degos, L. Acute promyelocytic leukaemia. N. Engl. J. Med. 329, 177-189 (1993).
3. Pandolfi, P.P. PML, PLZF and NPM in the pathogenesis of Acute Promyelocytic Leukaemia. Haematol. 81, 472-482 (1996).
4. Kalantry, S. et al. Gene rearrangements in the molecular pathogenesis of Acute Promyelocytic Leukaemia. J. Cell. Phys. 173, 288-296 (1997).
5. Pandolfi, P.P. et al. Structure and origin of the acute promyelocytic leukaemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6, 1285-1292 (1991).
6. Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukaemia fuses RARα with a novel putative transcription factor, PML. Cell 66, 663-674 (1991).
7. de The, H. et al. The PML/RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukaemia encodes a functionally altered RAR. Cell 66, 675-684 (1991).
8. Goddard, A.D., Borrow, J., Freemont, I. & Solomon, E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukaemia. Science 254, 1371-1374 (1991).
9. Chen, Z. et al. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic luekaemia. EMBO J. 12, 1161-1167 (1993).
10. Pandolfi, P.P. et al. Genomic variability and alternative splicings generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemias. EMBO J. 11, 1397-1407 (1992).
11. Reddy, B.A., Etkin, L.D. & Freemont, P.S. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci. 17, 344-345 (1992).
12. Li, J.Y. et al. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukaemia zinc finger protein. J. Biol. Chem. 272, 22447-22455 (1997).
13. Koken, M.H.M. et al. Leukaemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies [In Process Citation]. Proc. Natl. Acad. Sci. USA 94, 10255-10260 (1997).
14. Chambon, P. A decade of molecular biology of retinoic acid receptors. Faseb J. 10, 940-954 (1996).
15. Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349-352 (1997).
16. Smith, M.A., Parkinson, D.R., Cheson, B.D. & Friedman, M.A. Retinoids in cancer therapy. J. Clin. Oncol. 10, 839-864 (1992).
17. Gudas, L., Sporn, M. & Roberts, A. in The Retinoids: Cellular biology and biochemistry of the retinoids. 443-520 (Raven Press, New-York, 1994).
18. Fenaux, P., Chomienne, C. & Degos, L. Acute Promyelocytic Leukaemia: Biology and Treatment. Sem. Onc. 24, 92-102 (1997).
19. Licht, J.D. et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukaemia associated with translocation (11;17). Blood 85, 1083-1094 (1995).
20. Ferez, A. et al. PML/RAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J. 12, 3171-3182 (1993).
21. Jansen, J.H. et al. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukaemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc. Natl. Acad. Sci. USA 92, 7401-7405 (1995).
22. Licht, J.D. et al. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-α chimera generated in t(11;17)-associated acute promyelocytic leukaemia. Oncogens 12, 323-336 (1996).
23. Dong, S. et al. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyetocytic leukaemia zinc finger-retinoic acid receptor-α fusion protein. Proc. Natl. Aead. Sci. USA 93, 3624-3629 (1996).
24. Kastner, P. et al. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukaemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11, 629-642 (1992).
25. Chen, Z. et al. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukaemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc. Natl. Acad. Sci. USA 91, 1178-1182 (1994).
26. Dyck, J. et al. A novel macromolecular structure is a target of the promyelocyteretinoic acid receptor oncoprotein. Cell 76, 333-343 (1994).
27. Koken, M.H.M. et al. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073-1083 (1994).
28. Weis, K. et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic luekemic cells. Cell 76, 345-356 (1994).
29. Nervi, C. et al. Characterization of the PML/RARα chimeric product of the acute promyelocytic leukaemia specific t(15;17) translocation. Cancer Res. 52, 3687-3692 (1992).
30. Ruthardt, M. et al. Opposite effects of the acute promyelocytic leukaemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling. Mol. Cell. Biol. 17, 4859-4869 (1997).
31. Yoshida, M., Horinouchi, S. & Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17, 423-430 (1995).
32. He, L.-Z. et al. Acute leukaemia with promyelocytic features in PML/RARα transgenic mice. Proc. Natl. Acad. Sci. USA 94, 5302-5307 (1997).
33. Goldman, J.M. Chronic myeloid leukaemia. Curr. Opin. Hematol. 4, 277-285 (1997).
34. Warrell, R.P., Jr. et al. Differentiation therapy of acute promyelocytic leukaemia with tretinoin (all-trans-retinoic acid). W. Engl. J. Med 324, 1385-1393 (1991).
35. Castaigne, S. et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukaemia. I. Clinical results. Blood 76, 1704-1709 (1990).
36. Chen, S.-J. et al. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukaemia zinc finger genes resulting from t(11;17)(q23;21) in a patient with acute promyelocytic leukaemia. 1. Clin. Invest. 91, 2260-2267 (1993).
37. Jansen, J.H., de Ridder, M.C., Erpelinck, C, Geertsma, W. & de Greef, G.E. Granulocytic Differentiation of t(11;17) Positive AML-M3 Cells. Stood 88, 3421-3173 (1996).
38. Grisolano, J.L., Wesselschmidt, R.L., Pelicci, P.O. & Ley, T.J. Altered myeloid development and acute leukaemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood 89, 376-387 (1997).
39. Brown, D. et at. A PMLRARa transgene initiates murine acute promyelocytic leukaemia. Proc. Natl. Acad. Sci. USA 94, 2551-2556 (1997).
40. Lafage-Pochitaloff, M. et al. Acute promyelocytic luekemia cases with nonreciprocal PML/RARα or RARα/PML fusion genes. Blood 85, 1169-1174 (1995).
41. Hong, S.H., David, G., Wong, C.W., Dejean, A. & Privalsky, M.L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukaemia. Proc. Natl. Acad. Sci. USA 94, 9028-9033 (1997).
42. Heinzel, T. et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression . Nature 387, 43-48 (1997).
43. Alland, L. et al. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression . Nature 387, 49-55 (1997).
44. Hassig, C.A., Fleischer, T.C., Billin, A.N., Schreiber, S.L. & Ayer, D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341-347 (1997).
45. Laherty, C.D. et al. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349-356 (1997).
46. Dermime, S. et al. Occurrence of resistance to retinoic acid in the acute promyelocytic leukaemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein. Blood 82, 1573-1577 (1993).
47. Shao, W., Benedetti, L., Lamph, W.W., Nervi, C. S Miller Jr., W.H. A Retinoid-Resistant Acute Promyelocytic Leukaemia Subclone Expresses a Dominant Negative PML-RARα Mutation. Blood 89, 4282-4289 (1997).
48. Ding, W. et al. Retinoic Acid receptor alpha (RARα)-region mutations in the PML-RARα fusion gene of acute promyelocytic leukaemia (APL) patients after relapse from all-trans retinoic acid (ATRA) therapy. Blood 90, 415a (1997).
49. Lea, M.A. & Tulsyan, N. Discordant effects of butyrate analogues on erythroleukaemia cell proliferation, differentiation and histone deacetylase. Anticancer, Res. 15, 879-883 (1995).
50. Darkin-Rattray, S.J. et al. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc. Natl. Acad. Sci. USA 93, 13143-13147 (1996).
51. Collins, A.F. et al. Oral Sodium Phenylbutyrate therapy in homozygous β-Thalassemia: a clinical trial. Blood 85, 43-49 (1995).
52. Rousselot, P. et al. The PML-RAR alpha gene product of the t(15; 17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene 9, 545-551 (1994).
53. Horlein, A.J. et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397-404 (1995).
54. Gaub, M.P. et al. Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp. Cell Res. 201, 335-346 (1992).
55. Borden, K.L.B, et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML EMBO J. 14, 1532-1541 (1995).
56. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation-by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
57. Longo, L. et al. Rearrangements and aberrant expression of the RARa gene in acute promyelocytic leukaemias. J. Exp. Med. 172, 1571-1575 (1990).
58. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular cloning: a laboratory manual. (Cold Spring Harbor Laboratory Press, Plainview, NY, 1989).
59. Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids, Res. 11, 1475-1489 (1983).